Ischemia-guided percutaneous coronary intervention for patients with stable coronary artery disease

Young-Hak Kim1, Seung-Jung Park

  • 1Asan Medical Center, Seoul, Korea.

Insights

Ischemia-guided revascularization is supported for stable coronary artery disease. Recent studies challenge complete anatomical revascularization, favoring functional assessments to identify ischemia-producing lesions for selective treatment.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Evidence

Background:

  • Current guidelines recommend ischemia-guided revascularization for stable coronary symptoms.
  • Revascularization often targets anatomical stenosis (percutaneous coronary intervention, coronary artery bypass surgery) without confirming myocardial ischemia.
  • Complete anatomical revascularization is traditionally favored, especially in multivessel disease.

Purpose of the Study:

  • To review the strengths and weaknesses of anatomical versus functional revascularization strategies.
  • To explore recent evidence contradicting the concept of complete anatomical revascularization.
  • To highlight the benefit of ischemia-guided selective revascularization based on functional evaluation.

Main Methods:

  • Review of current evidence and guidelines.
  • Analysis of observational studies on revascularization strategies.
  • Exploration of noninvasive and invasive functional evaluation techniques.

Main Results:

  • Observational studies suggest benefits of ischemia-guided selective revascularization.
  • Functional evaluation identifies ischemia-producing coronary lesions.
  • Angiographic complete revascularization may not be superior.

Conclusions:

  • Ischemia-guided selective revascularization shows promise, particularly for multivessel disease.
  • Functional assessment of coronary lesions is crucial for optimal treatment.
  • Further trials are needed to definitively compare anatomical vs. functional revascularization.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...